Journal article is so 2021 PM get with the times. UK approvals are in, journal articles are out. When 2023 rolls around it will evolve to worldwide drug approvals vs any individual market. The journal will rarely be mentioned and DI’s consistent response to any questioning will be “we are working very very very very hard to get this to the finish line”